276 related articles for article (PubMed ID: 18928409)
21. Functional genomic studies: insights into the pathogenesis of liver cancer.
Han ZG
Annu Rev Genomics Hum Genet; 2012; 13():171-205. PubMed ID: 22703171
[TBL] [Abstract][Full Text] [Related]
22. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.
Tu T; Budzinska MA; Shackel NA; Jilbert AR
Liver Int; 2015 Jul; 35(7):1786-800. PubMed ID: 25640596
[TBL] [Abstract][Full Text] [Related]
23. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
24. Promotion of hepatocellular carcinoma by hepatitis C virus.
Bühler S; Bartenschlager R
Dig Dis; 2012; 30(5):445-52. PubMed ID: 23108300
[TBL] [Abstract][Full Text] [Related]
25. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress and epigenetic instability in human hepatocarcinogenesis.
Nishida N; Kudo M
Dig Dis; 2013; 31(5-6):447-53. PubMed ID: 24281019
[TBL] [Abstract][Full Text] [Related]
27. Micronuclei and broken eggs in human liver carcinogenesis.
Guido M; Fassan M; Giacomelli L; Cillo U; Farinati F; Burra P; Fagiuoli S; Rugge M
Anticancer Res; 2008; 28(4C):2507-11. PubMed ID: 18751442
[TBL] [Abstract][Full Text] [Related]
28. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis viruses and hepatocarcinogenesis].
Kiss A; Lotz G; Kaposi NP; Schaff Z
Orv Hetil; 2002 Jan; 143(2):83-6. PubMed ID: 11868453
[TBL] [Abstract][Full Text] [Related]
30. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
[TBL] [Abstract][Full Text] [Related]
32. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
33. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
35. New epidemiological data on liver oncogenesis.
Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2000; 47(33):855-61. PubMed ID: 10919047
[TBL] [Abstract][Full Text] [Related]
36. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.
Smith MW; Yue ZN; Geiss GK; Sadovnikova NY; Carter VS; Boix L; Lazaro CA; Rosenberg GB; Bumgarner RE; Fausto N; Bruix J; Katze MG
Cancer Res; 2003 Feb; 63(4):859-64. PubMed ID: 12591738
[TBL] [Abstract][Full Text] [Related]
38. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
39. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus-induced hepatocellular carcinoma.
Xu C; Zhou W; Wang Y; Qiao L
Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
